D
Amedisys, Inc.
AMED
$94.74
$0.1930.20%
D
Sell
4/26/2024Downgrade
Amedisys, Inc. (AMED) was downgraded to D from D+ on 4/26/2024 due to a decline in the efficiency index, total return index and volatility index. Net income declined 25.47% from $19.32M to $14.4M.
Amedisys, Inc. (AMED) was downgraded to D from D+ on 4/26/2024 due to a decline in the efficiency index, total return index and volatility index. Net income declined 25.47% from $19.32M to $14.4M.
D
Sell
4/11/2024Upgraded
Amedisys, Inc. (AMED) was upgraded to D+ from D on 4/11/2024 due to an increase in the total return index.
Amedisys, Inc. (AMED) was upgraded to D+ from D on 4/11/2024 due to an increase in the total return index.
D
Sell
3/27/2024Downgrade
Amedisys, Inc. (AMED) was downgraded to D from D+ on 3/27/2024 due to a noticeable decline in the growth index, efficiency index and solvency index. Earnings per share declined from $0.79 to $0.584, net income declined 25.57% from $25.96M to $19.32M, and EBIT declined 3.52% from $47.19M to $45.53M.
Amedisys, Inc. (AMED) was downgraded to D from D+ on 3/27/2024 due to a noticeable decline in the growth index, efficiency index and solvency index. Earnings per share declined from $0.79 to $0.584, net income declined 25.57% from $25.96M to $19.32M, and EBIT declined 3.52% from $47.19M to $45.53M.
D
Sell
10/26/2023Upgraded
Amedisys, Inc. (AMED) was upgraded to D+ from D on 10/26/2023 due to a noticeable increase in the growth index and solvency index. Earnings per share increased from -$2.464 to $0.79, EBIT increased 24.86% from $37.8M to $47.19M, and the quick ratio increased from 0.81 to 0.85.
Amedisys, Inc. (AMED) was upgraded to D+ from D on 10/26/2023 due to a noticeable increase in the growth index and solvency index. Earnings per share increased from -$2.464 to $0.79, EBIT increased 24.86% from $37.8M to $47.19M, and the quick ratio increased from 0.81 to 0.85.
D
Sell
10/10/2023Downgrade
Amedisys, Inc. (AMED) was downgraded to D from D+ on 10/10/2023 due to a decline in the volatility index and total return index.
Amedisys, Inc. (AMED) was downgraded to D from D+ on 10/10/2023 due to a decline in the volatility index and total return index.
D
Sell
9/22/2023Upgraded
Amedisys, Inc. (AMED) was upgraded to D+ from D on 9/22/2023 due to an increase in the volatility index and total return index.
Amedisys, Inc. (AMED) was upgraded to D+ from D on 9/22/2023 due to an increase in the volatility index and total return index.
D
Sell
9/5/2023Downgrade
Amedisys, Inc. (AMED) was downgraded to D from D+ on 9/5/2023 due to a decline in the volatility index.
Amedisys, Inc. (AMED) was downgraded to D from D+ on 9/5/2023 due to a decline in the volatility index.
D
Sell
8/17/2023Upgraded
Amedisys, Inc. (AMED) was upgraded to D+ from D on 8/17/2023 due to an increase in the volatility index and total return index.
Amedisys, Inc. (AMED) was upgraded to D+ from D on 8/17/2023 due to an increase in the volatility index and total return index.
D
Sell
7/31/2023Downgrade
Amedisys, Inc. (AMED) was downgraded to D from D+ on 7/31/2023 due to a significant decline in the valuation index, growth index and efficiency index. Earnings per share declined from $0.77 to -$2.464, net income declined 417.97% from $25.25M to -$80.28M, and EBIT declined 10.82% from $42.38M to $37.8M.
Amedisys, Inc. (AMED) was downgraded to D from D+ on 7/31/2023 due to a significant decline in the valuation index, growth index and efficiency index. Earnings per share declined from $0.77 to -$2.464, net income declined 417.97% from $25.25M to -$80.28M, and EBIT declined 10.82% from $42.38M to $37.8M.
D
Sell
9/13/2022Downgrade
Amedisys, Inc. (AMED) was downgraded to D+ from C- on 9/13/2022 due to a decline in the volatility index.
Amedisys, Inc. (AMED) was downgraded to D+ from C- on 9/13/2022 due to a decline in the volatility index.
C
Hold
8/25/2022Upgraded
Amedisys, Inc. (AMED) was upgraded to C- from D+ on 8/25/2022 due to an increase in the volatility index and valuation index.
Amedisys, Inc. (AMED) was upgraded to C- from D+ on 8/25/2022 due to an increase in the volatility index and valuation index.
D
Sell
8/2/2022Downgrade
Amedisys, Inc. (AMED) was downgraded to D+ from C- on 8/2/2022 due to a large decline in the growth index, valuation index and total return index. Earnings per share declined from $0.97 to $0.9095, and EBIT declined 2.54% from $51.96M to $50.64M.
Amedisys, Inc. (AMED) was downgraded to D+ from C- on 8/2/2022 due to a large decline in the growth index, valuation index and total return index. Earnings per share declined from $0.97 to $0.9095, and EBIT declined 2.54% from $51.96M to $50.64M.
C
Hold
5/27/2022Downgrade
Amedisys, Inc. (AMED) was downgraded to C- from C on 5/27/2022 due to a significant decline in the growth index, volatility index and total return index. Earnings per share declined from $1.0368 to $0.97, total revenue declined 2.51% from $559.32M to $545.26M, and EBIT declined 0.38% from $52.16M to $51.96M.
Amedisys, Inc. (AMED) was downgraded to C- from C on 5/27/2022 due to a significant decline in the growth index, volatility index and total return index. Earnings per share declined from $1.0368 to $0.97, total revenue declined 2.51% from $559.32M to $545.26M, and EBIT declined 0.38% from $52.16M to $51.96M.
C
Hold
9/29/2021Downgrade
Amedisys, Inc. (AMED) was downgraded to C from C+ on 9/29/2021 due to a decline in the total return index and volatility index.
Amedisys, Inc. (AMED) was downgraded to C from C+ on 9/29/2021 due to a decline in the total return index and volatility index.
C
Hold
9/15/2021Downgrade
Amedisys, Inc. (AMED) was downgraded to C+ from B- on 9/15/2021 due to a decline in the volatility index and total return index.
Amedisys, Inc. (AMED) was downgraded to C+ from B- on 9/15/2021 due to a decline in the volatility index and total return index.
B
Buy
8/23/2021Downgrade
Amedisys, Inc. (AMED) was downgraded to B- from B on 8/23/2021 due to a decline in the volatility index and total return index.
Amedisys, Inc. (AMED) was downgraded to B- from B on 8/23/2021 due to a decline in the volatility index and total return index.
B
Buy
8/6/2021Upgraded
Amedisys, Inc. (AMED) was upgraded to B from B- on 8/6/2021 due to an increase in the valuation index, growth index and solvency index. Earnings per share increased from $1.5 to $2.43, debt to equity declined from 0.34 to 0.25, and operating cash flow increased 25.84% from $54M to $67.96M.
Amedisys, Inc. (AMED) was upgraded to B from B- on 8/6/2021 due to an increase in the valuation index, growth index and solvency index. Earnings per share increased from $1.5 to $2.43, debt to equity declined from 0.34 to 0.25, and operating cash flow increased 25.84% from $54M to $67.96M.
B
Buy
8/5/2021Downgrade
Amedisys, Inc. (AMED) was downgraded to B- from B on 8/5/2021 due to a significant decline in the total return index, volatility index and solvency index. Debt to equity increased from 0.3 to 0.34.
Amedisys, Inc. (AMED) was downgraded to B- from B on 8/5/2021 due to a significant decline in the total return index, volatility index and solvency index. Debt to equity increased from 0.3 to 0.34.
B
Buy
10/8/2020Upgraded
Amedisys, Inc. (AMED) was upgraded to B from B- on 10/8/2020 due to a noticeable increase in the total return index and volatility index.
Amedisys, Inc. (AMED) was upgraded to B from B- on 10/8/2020 due to a noticeable increase in the total return index and volatility index.
B
Buy
9/23/2020Downgrade
Amedisys, Inc. (AMED) was downgraded to B- from B on 9/23/2020 due to a decline in the total return index.
Amedisys, Inc. (AMED) was downgraded to B- from B on 9/23/2020 due to a decline in the total return index.
B
Buy
9/3/2020Upgraded
Amedisys, Inc. (AMED) was upgraded to B from B- on 9/3/2020 due to a large increase in the total return index and volatility index.
Amedisys, Inc. (AMED) was upgraded to B from B- on 9/3/2020 due to a large increase in the total return index and volatility index.
B
Buy
8/19/2020Downgrade
Amedisys, Inc. (AMED) was downgraded to B- from B on 8/19/2020 due to a large decline in the total return index and valuation index.
Amedisys, Inc. (AMED) was downgraded to B- from B on 8/19/2020 due to a large decline in the total return index and valuation index.
B
Buy
8/3/2020Upgraded
Amedisys, Inc. (AMED) was upgraded to B from B- on 8/3/2020 due to an increase in the growth index, total return index and volatility index. Operating cash flow increased 2,119.09% from $6.04M to $133.92M, earnings per share increased from $0.96 to $1.04, and EBIT increased 0.63% from $44.87M to $45.15M.
Amedisys, Inc. (AMED) was upgraded to B from B- on 8/3/2020 due to an increase in the growth index, total return index and volatility index. Operating cash flow increased 2,119.09% from $6.04M to $133.92M, earnings per share increased from $0.96 to $1.04, and EBIT increased 0.63% from $44.87M to $45.15M.
B
Buy
7/23/2020Downgrade
Amedisys, Inc. (AMED) was downgraded to B- from B on 7/23/2020 due to a decline in the valuation index.
Amedisys, Inc. (AMED) was downgraded to B- from B on 7/23/2020 due to a decline in the valuation index.
B
Buy
6/23/2020Upgraded
Amedisys, Inc. (AMED) was upgraded to B from B- on 6/23/2020 due to an increase in the total return index and valuation index.
Amedisys, Inc. (AMED) was upgraded to B from B- on 6/23/2020 due to an increase in the total return index and valuation index.
B
Buy
6/5/2020Downgrade
Amedisys, Inc. (AMED) was downgraded to B- from B on 6/5/2020 due to a decline in the valuation index, efficiency index and growth index. Operating cash flow declined 91.98% from $75.22M to $6.04M, and total revenue declined 1.8% from $500.68M to $491.69M.
Amedisys, Inc. (AMED) was downgraded to B- from B on 6/5/2020 due to a decline in the valuation index, efficiency index and growth index. Operating cash flow declined 91.98% from $75.22M to $6.04M, and total revenue declined 1.8% from $500.68M to $491.69M.
B
Buy
3/31/2020Upgraded
Amedisys, Inc. (AMED) was upgraded to B from B- on 3/31/2020 due to an increase in the total return index.
Amedisys, Inc. (AMED) was upgraded to B from B- on 3/31/2020 due to an increase in the total return index.
B
Buy
3/16/2020Downgrade
Amedisys, Inc. (AMED) was downgraded to B- from B on 3/16/2020 due to a noticeable decline in the total return index, valuation index and volatility index.
Amedisys, Inc. (AMED) was downgraded to B- from B on 3/16/2020 due to a noticeable decline in the total return index, valuation index and volatility index.
B
Buy
11/5/2019Downgrade
Amedisys, Inc. (AMED) was downgraded to B from B+ on 11/5/2019 due to a noticeable decline in the growth index and valuation index. Operating cash flow declined 19.93% from $59.27M to $47.46M.
Amedisys, Inc. (AMED) was downgraded to B from B+ on 11/5/2019 due to a noticeable decline in the growth index and valuation index. Operating cash flow declined 19.93% from $59.27M to $47.46M.
B
Buy
10/7/2019Upgraded
Amedisys, Inc. (AMED) was upgraded to B+ from B on 10/7/2019 due to a significant increase in the total return index, volatility index and valuation index.
Amedisys, Inc. (AMED) was upgraded to B+ from B on 10/7/2019 due to a significant increase in the total return index, volatility index and valuation index.
B
Buy
8/2/2019Upgraded
Amedisys, Inc. (AMED) was upgraded to B from B- on 8/2/2019 due to an increase in the growth index, solvency index and efficiency index. Operating cash flow increased 195.46% from $20.06M to $59.27M, debt to equity declined from 0.64 to 0.53, and net income increased 7.79% from $31.3M to $33.74M.
Amedisys, Inc. (AMED) was upgraded to B from B- on 8/2/2019 due to an increase in the growth index, solvency index and efficiency index. Operating cash flow increased 195.46% from $20.06M to $59.27M, debt to equity declined from 0.64 to 0.53, and net income increased 7.79% from $31.3M to $33.74M.
B
Buy
5/16/2019Downgrade
Amedisys, Inc. (AMED) was downgraded to B- from B on 5/16/2019 due to a significant decline in the total return index, growth index and solvency index. Debt to equity increased from 0.02 to 0.75, operating cash flow declined 68.67% from $64.03M to $20.06M, and the quick ratio declined from 0.96 to 0.83.
Amedisys, Inc. (AMED) was downgraded to B- from B on 5/16/2019 due to a significant decline in the total return index, growth index and solvency index. Debt to equity increased from 0.02 to 0.75, operating cash flow declined 68.67% from $64.03M to $20.06M, and the quick ratio declined from 0.96 to 0.83.
B
Buy
8/3/2018Upgraded
Amedisys, Inc. (AMED) was upgraded to B from B- on 8/3/2018 due to a major increase in the valuation index, growth index and efficiency index. Operating cash flow increased 25.64% from $40.32M to $50.65M, earnings per share increased from $0.79 to $0.98, and net income increased 22.79% from $27.16M to $33.35M.
Amedisys, Inc. (AMED) was upgraded to B from B- on 8/3/2018 due to a major increase in the valuation index, growth index and efficiency index. Operating cash flow increased 25.64% from $40.32M to $50.65M, earnings per share increased from $0.79 to $0.98, and net income increased 22.79% from $27.16M to $33.35M.
B
Buy
7/10/2018Upgraded
Amedisys, Inc. (AMED) was upgraded to B- from C+ on 7/10/2018 due to an increase in the volatility index and total return index.
Amedisys, Inc. (AMED) was upgraded to B- from C+ on 7/10/2018 due to an increase in the volatility index and total return index.
C
Hold
6/25/2018Downgrade
Amedisys, Inc. (AMED) was downgraded to C+ from B- on 6/25/2018 due to a decline in the valuation index.
Amedisys, Inc. (AMED) was downgraded to C+ from B- on 6/25/2018 due to a decline in the valuation index.
B
Buy
5/10/2018Upgraded
Amedisys, Inc. (AMED) was upgraded to B- from C on 5/10/2018 due to a significant increase in the growth index, total return index and valuation index. Earnings per share increased from -$0.12 to $0.79, operating cash flow increased 25.25% from $32.19M to $40.32M, and EBIT increased 13.69% from $31.67M to $36.01M.
Amedisys, Inc. (AMED) was upgraded to B- from C on 5/10/2018 due to a significant increase in the growth index, total return index and valuation index. Earnings per share increased from -$0.12 to $0.79, operating cash flow increased 25.25% from $32.19M to $40.32M, and EBIT increased 13.69% from $31.67M to $36.01M.
C
Hold
3/8/2018Downgrade
Amedisys, Inc. (AMED) was downgraded to C from C+ on 3/8/2018 due to a significant decline in the growth index, valuation index and efficiency index. Earnings per share declined from $0.42 to -$0.12, and net income declined 126.43% from $14.56M to -$3.85M.
Amedisys, Inc. (AMED) was downgraded to C from C+ on 3/8/2018 due to a significant decline in the growth index, valuation index and efficiency index. Earnings per share declined from $0.42 to -$0.12, and net income declined 126.43% from $14.56M to -$3.85M.
C
Hold
2/20/2018Downgrade
Amedisys, Inc. (AMED) was downgraded to C+ from B- on 2/20/2018 due to a decline in the valuation index and volatility index.
Amedisys, Inc. (AMED) was downgraded to C+ from B- on 2/20/2018 due to a decline in the valuation index and volatility index.
B
Buy
1/4/2018Upgraded
Amedisys, Inc. (AMED) was upgraded to B- from C+ on 1/4/2018 due to an increase in the total return index, solvency index and valuation index. The quick ratio increased from 1.03 to 1.21, and debt to equity declined from 0.19 to 0.18.
Amedisys, Inc. (AMED) was upgraded to B- from C+ on 1/4/2018 due to an increase in the total return index, solvency index and valuation index. The quick ratio increased from 1.03 to 1.21, and debt to equity declined from 0.19 to 0.18.
C
Hold
11/6/2017Downgrade
Amedisys, Inc. (AMED) was downgraded to C+ from B- on 11/6/2017 due to a decline in the volatility index and total return index.
Amedisys, Inc. (AMED) was downgraded to C+ from B- on 11/6/2017 due to a decline in the volatility index and total return index.
B
Buy
10/13/2017Upgraded
Amedisys, Inc. (AMED) was upgraded to B- from C+ on 10/13/2017 due to an increase in the volatility index, total return index and solvency index.
Amedisys, Inc. (AMED) was upgraded to B- from C+ on 10/13/2017 due to an increase in the volatility index, total return index and solvency index.
C
Hold
8/23/2017Downgrade
Amedisys, Inc. (AMED) was downgraded to C+ from B- on 8/23/2017 due to a decline in the valuation index.
Amedisys, Inc. (AMED) was downgraded to C+ from B- on 8/23/2017 due to a decline in the valuation index.
B
Buy
8/8/2017Upgraded
Amedisys, Inc. (AMED) was upgraded to B- from C+ on 8/8/2017 due to a significant increase in the growth index, volatility index and solvency index. Operating cash flow increased 33.76% from $27.1M to $36.24M, EBIT increased 15.05% from $25.17M to $28.95M, and total revenue increased 2.76% from $364.12M to $374.17M.
Amedisys, Inc. (AMED) was upgraded to B- from C+ on 8/8/2017 due to a significant increase in the growth index, volatility index and solvency index. Operating cash flow increased 33.76% from $27.1M to $36.24M, EBIT increased 15.05% from $25.17M to $28.95M, and total revenue increased 2.76% from $364.12M to $374.17M.
C
Hold
5/10/2017Upgraded
Amedisys, Inc. (AMED) was upgraded to C+ from C on 5/10/2017 due to a noticeable increase in the valuation index, efficiency index and solvency index. Net income increased 69.68% from $8.92M to $15.13M, the quick ratio increased from 1.1 to 1.2, and debt to equity declined from 0.2 to 0.19.
Amedisys, Inc. (AMED) was upgraded to C+ from C on 5/10/2017 due to a noticeable increase in the valuation index, efficiency index and solvency index. Net income increased 69.68% from $8.92M to $15.13M, the quick ratio increased from 1.1 to 1.2, and debt to equity declined from 0.2 to 0.19.
C
Hold
4/24/2017Downgrade
Amedisys, Inc. (AMED) was downgraded to C from C+ on 4/24/2017 due to a decline in the valuation index.
Amedisys, Inc. (AMED) was downgraded to C from C+ on 4/24/2017 due to a decline in the valuation index.
C
Hold
3/27/2017Upgraded
Amedisys, Inc. (AMED) was upgraded to C+ from C on 3/27/2017 due to a large increase in the efficiency index and total return index. Total capital increased 2.53% from $540.47M to $554.17M.
Amedisys, Inc. (AMED) was upgraded to C+ from C on 3/27/2017 due to a large increase in the efficiency index and total return index. Total capital increased 2.53% from $540.47M to $554.17M.
C
Hold
8/22/2016Downgrade
Amedisys Inc. (AMED) was downgraded to C from C+ on 8/22/2016 due to a large decline in the total return index.
Amedisys Inc. (AMED) was downgraded to C from C+ on 8/22/2016 due to a large decline in the total return index.
C
Hold
8/5/2016Upgraded
Amedisys Inc. (AMED) was upgraded to C+ from C on 8/5/2016 due to a substantial increase in the growth index, efficiency index and valuation index. Net income increased 72.16% from $6.21M to $10.7M, earnings per share increased from $0.1887 to $0.32, and EBIT increased 65.94% from $11.06M to $18.36M.
Amedisys Inc. (AMED) was upgraded to C+ from C on 8/5/2016 due to a substantial increase in the growth index, efficiency index and valuation index. Net income increased 72.16% from $6.21M to $10.7M, earnings per share increased from $0.1887 to $0.32, and EBIT increased 65.94% from $11.06M to $18.36M.
C
Hold
4/15/2016Upgraded
Amedisys Inc. (AMED) was upgraded to C from C- on 4/15/2016 due to a substantial increase in the total return index.
Amedisys Inc. (AMED) was upgraded to C from C- on 4/15/2016 due to a substantial increase in the total return index.
C
Hold
4/6/2016Upgraded
Amedisys Inc. (AMED) was upgraded to C- from D+ on 4/6/2016 due to an increase in the total return index and volatility index.
Amedisys Inc. (AMED) was upgraded to C- from D+ on 4/6/2016 due to an increase in the total return index and volatility index.
D
Sell
3/11/2016Downgrade
Amedisys Inc. (AMED) was downgraded to D+ from C- on 3/11/2016 due to a significant decline in the volatility index and total return index.
Amedisys Inc. (AMED) was downgraded to D+ from C- on 3/11/2016 due to a significant decline in the volatility index and total return index.
C
Hold
11/10/2015Downgrade
Amedisys Inc. (AMED) was downgraded to C- from C on 11/10/2015 due to a decline in the growth index, efficiency index and valuation index. Operating cash flow declined 27.85% from $42.55M to $30.7M, earnings per share declined from $0.32 to $0.25, and net income declined 20.65% from $10.64M to $8.44M.
Amedisys Inc. (AMED) was downgraded to C- from C on 11/10/2015 due to a decline in the growth index, efficiency index and valuation index. Operating cash flow declined 27.85% from $42.55M to $30.7M, earnings per share declined from $0.32 to $0.25, and net income declined 20.65% from $10.64M to $8.44M.
C
Hold
6/18/2015Upgraded
Amedisys Inc. (AMED) was upgraded to C from C- on 6/18/2015 due to an increase in the total return index.
Amedisys Inc. (AMED) was upgraded to C from C- on 6/18/2015 due to an increase in the total return index.
C
Hold
5/1/2015Downgrade
Amedisys Inc. (AMED) was downgraded to C- from C on 5/1/2015 due to a noticeable decline in the efficiency index, total return index and valuation index. Net income declined 483.24% from $9.14M to -$35.01M, and total capital declined 9.39% from $514.13M to $465.88M.
Amedisys Inc. (AMED) was downgraded to C- from C on 5/1/2015 due to a noticeable decline in the efficiency index, total return index and valuation index. Net income declined 483.24% from $9.14M to -$35.01M, and total capital declined 9.39% from $514.13M to $465.88M.
C
Hold
3/23/2015Downgrade
Amedisys Inc. (AMED) was downgraded to C from C+ on 3/23/2015 due to a noticeable decline in the total return index.
Amedisys Inc. (AMED) was downgraded to C from C+ on 3/23/2015 due to a noticeable decline in the total return index.
C
Hold
3/6/2015Upgraded
Amedisys Inc. (AMED) was upgraded to C+ from C on 3/6/2015 due to a major increase in the total return index, efficiency index and valuation index. Net income increased 8.25% from $8.44M to $9.14M, and total capital increased 3.36% from $497.4M to $514.13M.
Amedisys Inc. (AMED) was upgraded to C+ from C on 3/6/2015 due to a major increase in the total return index, efficiency index and valuation index. Net income increased 8.25% from $8.44M to $9.14M, and total capital increased 3.36% from $497.4M to $514.13M.
C
Hold
10/31/2014Upgraded
Amedisys Inc. (AMED) was upgraded to C from C- on 10/31/2014 due to a significant increase in the volatility index, growth index and total return index. EBIT increased 29.35% from $12.56M to $16.25M, and earnings per share increased from $0.2319 to $0.2599.
Amedisys Inc. (AMED) was upgraded to C from C- on 10/31/2014 due to a significant increase in the volatility index, growth index and total return index. EBIT increased 29.35% from $12.56M to $16.25M, and earnings per share increased from $0.2319 to $0.2599.
C
Hold
8/6/2014Upgraded
Amedisys Inc. (AMED) was upgraded to C- from D+ on 8/6/2014 due to a noticeable increase in the volatility index, total return index and efficiency index. Total capital increased 26.97% from $405.87M to $515.32M.
Amedisys Inc. (AMED) was upgraded to C- from D+ on 8/6/2014 due to a noticeable increase in the volatility index, total return index and efficiency index. Total capital increased 26.97% from $405.87M to $515.32M.
D
Sell
3/14/2014Upgraded
Amedisys Inc. (AMED) was upgraded to D+ from D on 3/14/2014 due to an increase in the efficiency index, growth index and solvency index. Debt to equity declined from 0.19 to 0.13, and total revenue increased 0.39% from $297.67M to $298.83M.
Amedisys Inc. (AMED) was upgraded to D+ from D on 3/14/2014 due to an increase in the efficiency index, growth index and solvency index. Debt to equity declined from 0.19 to 0.13, and total revenue increased 0.39% from $297.67M to $298.83M.
NASDAQ
05/10/2024 11:19AM Eastern
Quotes delayed
